A Loved One’s Tale

  • Video transcript | 2:21

    TEXT ONSCREEN:

    TALES OF BREATHLESSNESS

    TEXT ONSCREEN:

    A LOVED ONE’S TALE

    A Grandmother’s Story Through Her Grandson’s Eyes

    VOICEOVER:

    My grandma is my biggest fan.

    VOICEOVER:

    She has been coming to every game for as long as I can remember.

    VOICEOVER:

    Come rain or shine,

    VOICEOVER:

    ...she’s always on the sidelines cheering me, but mainly yelling out ‘tactics’ and ‘advice’.

    VOICEOVER:

    Honestly, she’s more vocal than our coach. [Slight laugh]

    VOICEOVER:

    But last season, that changed.

    VOICEOVER:

    My grandma has had COPD for a while, and she had been taking a maintenance inhaler twice a day.

    VOICEOVER:

    But she started coughing all the time and missing a lot of my games.

    VOICEOVER:

    One day she was so bad, she couldn’t walk more than a few steps before stopping to catch her breath. I knew she needed to get help.

    TEXT ONSCREEN:

    Even when they were prescribed FP/SAL, an ICS/LABA, nearly 90% of patients with COPD had a high symptom burden (CAT≥10)*

    *Based on data from an observational claims-linked survey of Medicare Advantage enrollees ≥65 years of age who had been prescribed FP/ SAL in the prior 6 months (n=397).

    Study Limitations: A claim for a prescription does not necessarily mean the medication was taken as prescribed. Diagnosis codes on medical claims do not conclusively demonstrate presence of disease. Findings may not be generalizable to uninsured or younger patient populations.

    VOICEOVER:

    It was a hard conversation to have with grandma, but I think she just needed the encouragement and support to go see her doctor again.

    VOICEOVER:

    At her appointment, the doctor asked grandma lots of questions about how her COPD was impacting her life. And how had her daily routine changed since he last saw her. She told him about her breathing difficulties and how she was finding it more challenging to come to my games.

    VOICEOVER:

    When he asked if her COPD was worrying her, she said her symptoms were keeping her from going out and she was scared she wouldn’t be able to care for me the same way. She was also worried she might not be able to take care of herself eventually. I had no idea she was so worried.

    TEXT ONSCREEN:

    How do your symptoms affect your daily activities?

    How often do your symptoms cause you to wake up at night?

    How do your symptoms affect how far you can walk or how many stairs you can climb?

    VOICEOVER:

    The doctor mentioned a few things that could help. Importantly, he recommended an increase in her treatment so he gave her a different inhaler.

    TEXT ONSCREEN:

    The 2021 GOLD Report supports escalation to triple therapy for patients with COPD who continue to experience persistent breathlessness or exacerbations on an ICS/LABA.

    TEXT ONSCREEN:

    If you have patients with COPD who remain symptomatic, it may be time to consider triple therapy.

    Trademarks are owned by or licensed to the GSK group of companies.

    [GSK logo]

    ©2021 GSK or licensor. FVUVID210026

    October 2021 Produced in USA.

    TEXT ONSCREEN:

    References

    1. Moretz C, et al. Int J Chron Obstruct Pulmon Dis. 2020;15:2715-2725. Supplementary Table 1.

    2. GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2021 report. www.goldcopd.org

    Definitions

    CAT=COPD Assessment Test; COPD=chronic obstructive pulmonary disease; FP=fluticasone propionate; GOLD=Global Initiative for Chronic Obstructive Lung Disease; ICS=inhaled corticosteroid; LABA=long-acting beta2-adrenergic agonist; SAL=salmeterol.

     

    Close transcript

3 dots